Scholars Central

Mini reviewPublished 28 Jul 2022

Biopharmaceutical Manufacturing: An Evolving Industry

Authors: James A Uchizono

Department of Pharmaceutics and Medicinal Chemistry, University of the Pacific, USA

Clinical Pharmacology & Biopharmaceutics

Volume 11 · Issue 7 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The biopharmaceutical assiduity is evolving with a shift in focus from recombinant proteins and antibodies towards more complex cell and gene curatives. To be competitive encyclopaedically, bio manufacturers need to concentrate on aligning with global norms with regard to medicine quality, reducing manufacturing failures and delivering medicines to vend snappily. Erecting these capabilities requires a multifaceted approach that includes advancements in operations, quality compliance, and control strategies. To address these requirements, the US Pharmacopeia (USP), the Department of Biotechnology (DBT) India, and the Confederation of Indian Industry (CII) held a council to bandy the conditions and gaps in the biotechnology and pharmaceutical sectors in India and other developing countries.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “James A Uchizono”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels